Education
About Us
Working with TipRanks
Follow Us
Gabather AB (DE:5J2)
FRANKFURT:5J2
5J2 Stock Chart & Stats
€0.01
>-€0.01(-5.13%)
At close: 4:00 PM EST
€0.01
>-€0.01(-5.13%)
Day’s Range― - ―
52-Week Range€0.00 - €0.02
Previous CloseN/A
Volume0.00
Average Volume (3M)1.71K
Market Cap
€691.99K
Enterprise Value€8.71M
Total Cash (Recent Filing)€3.00M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta4.50
Next Earnings
Feb 26, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding236,204,880
10 Day Avg. Volume1,710
30 Day Avg. Volume1,710
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-1.98
Price to Sales (P/S)0.00
P/FCF Ratio-2.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
5J2 FAQ
What was Gabather AB’s price range in the past 12 months?
Gabather AB lowest stock price was €0.00 and its highest was €0.01 in the past 12 months.
What is Gabather AB’s market cap?
Gabather AB’s market cap is €691.99K.
When is Gabather AB’s upcoming earnings report date?
Gabather AB’s upcoming earnings report date is Feb 26, 2026 which is in 71 days.
How were Gabather AB’s earnings last quarter?
Gabather AB released its earnings results on Nov 27, 2025. The company reported €0 earnings per share for the quarter, the consensus estimate of €0 by €0.
Is Gabather AB overvalued?
According to Wall Street analysts Gabather AB’s price is currently Overvalued.
Does Gabather AB pay dividends?
Gabather AB does not currently pay dividends.
What is Gabather AB’s EPS estimate?
Gabather AB’s EPS estimate is 0.
How many shares outstanding does Gabather AB have?
Gabather AB has 236,204,880 shares outstanding.
What happened to Gabather AB’s price movement after its last earnings report?
Gabather AB reported an EPS of €0 in its last earnings report, expectations of €0. Following the earnings report the stock price went down -33.333%.
Which hedge fund is a major shareholder of Gabather AB?
Currently, no hedge funds are holding shares in DE:5J2
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Gabather AB
Gabather AB (publ) develops drug candidates for the treatment of central nervous system diseases. It offers drugs primarily in the areas of anti-psychotics; anti-depressants and anxiolytics; analgesics; and cognition-enhancing treatments, including Alzheimer's disease. The company was incorporated in 2014 and is based in Södertälje Sweden.
AlzeCure Pharma AB
―
Vivesto AB
―
Klaria Pharma Holding AB
―
Nanexa AB
―
Enorama Pharma AB
―